| From cytokine to myokine: the emerging role of interleukin‐6 in metabolic regulation M Pal, MA Febbraio, M Whitham Immunology and cell biology 92 (4), 331-339, 2014 | 290 | 2014 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 273 | 2021 |
| Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism BF Belgardt, J Mauer, FT Wunderlich, MB Ernst, M Pal, G Spohn, ... Proceedings of the National Academy of Sciences 107 (13), 6028-6033, 2010 | 189 | 2010 |
| The roles of c‐Jun NH2‐terminal kinases (JNKs) in obesity and insulin resistance M Pal, MA Febbraio, GI Lancaster The Journal of physiology 594 (2), 267-279, 2016 | 131 | 2016 |
| Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1 M Whitham, MHS Chan, M Pal, VB Matthews, O Prelovsek, S Lunke, ... Journal of Biological Chemistry 287 (14), 10771-10779, 2012 | 122 | 2012 |
| Loss of Roquin induces early death and immune deregulation but not autoimmunity A Bertossi, M Aichinger, P Sansonetti, M Lech, F Neff, M Pal, ... Journal of Experimental Medicine 208 (9), 1749-1756, 2011 | 119 | 2011 |
| Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance E Tsaousidou, L Paeger, BF Belgardt, M Pal, CM Wunderlich, H Brönneke, ... Cell reports 9 (4), 1495-1506, 2014 | 115 | 2014 |
| Mosaic deficiency in mitochondrial oxidative metabolism promotes cardiac arrhythmia during aging OR Baris, S Ederer, JFG Neuhaus, JC von Kleist-Retzow, CM Wunderlich, ... Cell metabolism 21 (5), 667-677, 2015 | 92 | 2015 |
| Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1 V Kohlhaas, SJ Blakemore, M Al-Maarri, N Nickel, M Pal, A Roth, ... Blood, The Journal of the American Society of Hematology 137 (5), 646-660, 2021 | 77 | 2021 |
| Treatment of type 2 diabetes with the designer cytokine IC7Fc M Findeisen, TL Allen, DC Henstridge, H Kammoun, AE Brandon, ... Nature 574 (7776), 63-68, 2019 | 70 | 2019 |
| TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1 L Lionnard, P Duc, MS Brennan, AJ Kueh, M Pal, F Guardia, B Mojsa, ... Cell Death & Differentiation 26 (5), 902-917, 2019 | 59 | 2019 |
| An update on using CRISPR/Cas9 in the one-cell stage mouse embryo for generating complex mutant alleles AJ Kueh, M Pal, L Tai, Y Liao, GK Smyth, W Shi, MJ Herold Cell Death & Differentiation 24 (10), 1821-1822, 2017 | 44 | 2017 |
| Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in mice M Pal, CM Wunderlich, G Spohn, HS Brönneke, M Schmidt-Supprian, ... PLoS One 8 (1), e54247, 2013 | 43 | 2013 |
| Adipocyte-specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice M Whitham, M Pal, T Petzold, M Hjorth, CL Egan, JS Brunner, E Estevez, ... American Journal of Physiology-Endocrinology and Metabolism 317 (4), E597-E604, 2019 | 29 | 2019 |
| Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance Y Deng, ST Diepstraten, MA Potts, G Giner, S Trezise, AP Ng, G Healey, ... Nature Communications 13 (1), 4739, 2022 | 15 | 2022 |
| CRISPR base editing applications for identifying cancer-driving mutations M Pal, MJ Herold Biochemical Society Transactions 49 (1), 269-280, 2021 | 12 | 2021 |
| Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis MA Potts, S Mizutani, AL Garnham, CSN Li Wai Suen, AJ Kueh, L Tai, ... Cell Death & Differentiation 30 (6), 1447-1456, 2023 | 7 | 2023 |
| LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin target in Tasmanian devil facial tumor disease MP Ikonomopoulou, Y Lopez-Mancheno, MG Novelle, M Martinez-Una, ... Cell Reports 34 (11), 2021 | 5 | 2021 |
| Generation of a CRISPR activationmouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance (vol 13, 4739, 2022) YX Deng, ST Diepstraten, MA Potts, G Giner, S Trezise, AP Ng, G Healey, ... Nature Communications 13 (1), 5007, 2022 | 4 | 2022 |
| Case Study: CRISPR 101–a novel online learning course harnessing innovative ways to teach a complex biomolecular technology M Pal, N Cranna, MJ Herold, K Bumsted O’Brien Essays in Biochemistry 66 (1), 11-18, 2022 | 3 | 2022 |
